Nuclear Transport of Ras-associated Tumor Suppressor Proteins: Different Transport Receptor Binding Specificities for Arginine-rich Nuclear Targeting Signals

Journal of Molecular Biology

Volumn 367, Issue 5, 2007, Pages 1294-1311

  Kumari, Gita ^a   Singhal, Prabhat K ^a   Rao, M R K Subba ^a   Mahalingam, S ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

Author keywords

arginine rich transport signals; nuclear localization; protein protein interaction; Ras effector proteins; transport receptors

Indexed keywords

ARGININE; BINDING PROTEIN; CARRIER PROTEIN; K RAS PROTEIN; KARYOPHERIN ALPHA; NUCLEAR PROTEIN; PROTEIN RASSF1C; PROTEIN RASSF2; PROTEIN RASSF5; RAS PROTEIN; RECEPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

EID: 33947099350     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.01.026     Document Type: Article

References (54)

1. Downward J. Targeting RAS signalling pathways in cancer therapy. Nature Rev. Cancer 3 (2003) 11-22
2. Lowy D.R., and Willumsen B.M. Function and regulation of ras. Annu. Rev. Biochem. 62 (1993) 851-891
3. Malumbres M., and Pellicer A. RAS pathways to cell cycle control and cell transformation. Front. Biosci. 3 (1998) d887-d912
4. Pfeifer G.P., Yoon J.H., Liu L., Tommasi S., Wilczynski S.P., and Dammann R. Methylation of the RASSF1A gene in human cancers. Biol. Chem. 383 (2002) 907-914
5. Agathanggelou A., Honorio S., Macartney D.P., Martinez A., Dallol A., Rader J., et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20 (2001) 1509-1518
6. Dammann R., Yang G., and Pfeifer G.P. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res. 61 (2001) 3105-3109
7. Elam C., Hesson L., Vos M.D., Eckfeld K., Ellis C.A., Bell A., et al. RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential. Cancer Res. 65 (2005) 3117-3125
8. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349 (2003) 2042-2054
9. Hesson L., Bieche I., Krex D., Criniere E., Hoang-Xuan K., Maher E.R., and Latif F. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 23 (2004) 2408-2419
10. Zhang Y.J., Ahsan H., Chen Y., Lunn R.M., Wang L.Y., Chen S.Y., et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol. Carcinogen 35 (2002) 85-92
11. Shields J.M., Pruitt K., McFall A., Shaub A., and Der C.J. Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol. 10 (2000) 147-154
12. Tommasi S., Dammann R., Zhang Z., Wang Y., Liu L., Tsark W.M., et al. Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 65 (2005) 92-98
13. Vos M.D., Dallol A., Eckfeld K., Allen N.P., Donninger H., Hesson L.B., et al. The RASSF1A tumor suppressor activates Bax via MOAP-1. J. Biol. Chem. 281 (2006) 4557-4563
14. Shivakumar L., Minna J., Sakamaki T., Pestell R., and White M.A. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell Biol. 22 (2002) 4309-4318
15. Song M.S., and Lim D.S. Control of APC-Cdc20 by the tumor suppressor RASSF1A. Cell Cycle 3 (2004) 574-576
16. Weber J.D., Taylor L.J., Roussel M.F., Sherr C.J., and Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1 (1999) 20-26
17. Llanos S., Clark P.A., Rowe J., and Peters G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nature Cell Biol. 3 (2001) 445-452
18. Sugimoto M., Kuo M.L., Roussel M.F., and Sherr C.J. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell 11 (2003) 415-424
19. Corbett A.H., and Silver P.A. Nucleocytoplasmic transport of macromolecules. Microbiol. Mol. Biol. Rev. 61 (1997) 193-211
20. Gorlich D. Nuclear protein import. Curr. Opin. Cell Biol. 9 (1997) 412-419
21. Gorlich D., and Mattaj I.W. Nucleocytoplasmic transport. Science 271 (1996) 1513-1518
22. Chan E.H., Nousiainen M., Chalamalasetty R.B., Schafer A., Nigg E.A., and Sillje H.H. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24 (2005) 2076-2086
23. Ohno M., Fornerod M., and Mattaj I.W. Nucleocytoplasmic transport: the last 200 nanometers. Cell 92 (1998) 327-336
24. Dingwall C., and Laskey R.A. Nuclear targeting sequences-a consensus?. Trends Biochem. Sci. 16 (1991) 478-481
25. Schickling O., Stegh A.H., Byrd J., and Peter M.E. Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription. Cell Death Differ. 8 (2001) 1157-1168
26. Truant R., and Cullen B.R. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol. Cell Biol. 19 (1999) 1210-1217
27. Palmeri D., and Malim M.H. Importin beta can mediate the nuclear import of an arginine-rich nuclear localization signal in the absence of importin alpha. Mol. Cell Biol. 19 (1999) 1218-1225
28. Nakielny S., and Dreyfuss G. Transport of proteins and RNAs in and out of the nucleus. Cell 99 (1999) 677-690
29. Berger M., Vogt Sionov R., Levine A.J., and Haupt Y. A role for the polyproline domain of p53 in its regulation by Mdm2. J. Biol. Chem. 276 (2001) 3785-3790
30. Hancock J.F. Ras proteins: different signals from different locations. Nature Rev. Mol. Cell Biol. 4 (2003) 373-384
31. Chestukhin A., Litovchick L., Rudich K., and DeCaprio J.A. Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism. Mol. Cell Biol. 22 (2002) 453-468
32. Thakur S., Zhang H.B., Peng Y., Le H., Carroll B., Ward T., et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell Biol. 17 (1997) 444-452
33. Fabbro M., and Henderson B.R. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Expt. Cell Res. 282 (2003) 59-69
34. Moshnikova A., Frye J., Shay J.W., Minna J.D., and Khokhlatchev A.V. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway. J. Biol. Chem. 281 (2006) 8143-8152
35. Agathanggelou A., Cooper W.N., and Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res. 65 (2005) 3497-3508
36. Vos M.D., Ellis C.A., Bell A., Birrer M.J., and Clark G.J. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275 (2000) 35669-35672
37. Khokhlatchev A., Rabizadeh S., Xavier R., Nedwidek M., Chen T., Zhang X.F., et al. Identification of a novel Ras-regulated proapoptotic pathway. Curr. Biol. 12 (2002) 253-265
38. Vos M.D., Ellis C.A., Elam C., Ulku A.S., Taylor B.J., and Clark G.J. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J. Biol. Chem. 278 (2003) 28045-28051
39. Praskova M., Khoklatchev A., Ortiz-Vega S., and Avruch J. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem. J. 381 (2004) 453-462
40. Vos M.D., Martinez A., Elam C., Dallol A., Taylor B.J., Latif F., and Clark G.J. A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res. 64 (2004) 4244-4250
41. Johnson L., Greenbaum D., Cichowski K., Mercer K., Murphy E., Schmitt E., et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11 (1997) 2468-2481
42. Ellis C.A., Vos M.D., Howell H., Vallecorsa T., Fults D.W., and Clark G.J. Rig is a novel Ras-related protein and potential neural tumor suppressor. Proc. Natl Acad. Sci. USA 99 (2002) 9876-9881
43. Song M.S., Song S.J., Ayad N.G., Chang J.S., Lee J.H., Hong H.K., et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nature Cell Biol. 6 (2004) 129-137
44. Ruggero D., and Pandolfi P.P. Does the ribosome translate cancer?. Nature Rev. Cancer 3 (2003) 179-192
45. Liu L., Tommasi S., Lee D.H., Dammann R., and Pfeifer G.P. Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22 (2003) 8125-8136
46. Ren R., Mayer B.J., Cicchetti P., and Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259 (1993) 1157-1161
47. Jakel S., and Gorlich D. Importin beta, transportin, RanBP5 and RanBP7 mediate nuclear import of ribosomal proteins in mammalian cells. EMBO J. 17 (1998) 4491-4502
48. Kotera I., Sekimoto T., Miyamoto Y., Saiwaki T., Nagoshi E., Sakagami H., et al. Importin alpha transports CaMKIV to the nucleus without utilizing importin beta. EMBO J. 24 (2005) 942-951
49. Bernardi R., and Pandolfi P.P. The nucleolus: at the stem of immortality. Nature Med. 9 (2003) 24-25
50. Fatica A., and Tollervey D. Making ribosomes. Curr. Opin. Cell Biol. 14 (2002) 313-318
51. Olson M.O., Hingorani K., and Szebeni A. Conventional and nonconventional roles of the nucleolus. Int. Rev. Cytol. 219 (2002) 199-266
52. Rajendra Kumar P., Singhal P.K., Subba Rao M.R., and Mahalingam S. Phosphorylation by MAPK regulates simian immunodeficiency virus Vpx protein nuclear import and virus infectivity. J. Biol. Chem. 280 (2005) 8553-8563
53. Sabichi A.L., Hendricks D.T., Bober M.A., and Birrer M.J. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. J. Natl Cancer Inst. 90 (1998) 597-605
54. Imamoto N., Shimamoto T., Takao T., Tachibana T., Kose S., Matsubae M., et al. In vivo evidence for involvement of a 58 kDa component of nuclear pore-targeting complex in nuclear protein import. EMBO J. 14 (1995) 3617-3626